Risk factors for antidepressant discontinuation syndrome, and guidance for its management
IV ketamine infusion is an option when conventional therapies fail to yield relief
The neuroactive steroid significantly reduces seizures related to CDKL5 deficiency disorder
Retrospective series characterizes post-COVID-19 POTS, outlines next research goals
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Integrates genetic and clinical data to distinguish from GEFS+ and milder epilepsies
Surgery can be a game changer when medications fail to control seizures
Assessing the role of circadian disruption, characterizing patterns of thalamic atrophy
Guidance for treatment, including the role of post-ICU recovery clinics
More evidence needed on pharmacologic therapy alone and combined with gait training
Comparative MRI study suggests unique pathophysiology in COVID-19 context
Advertisement
Advertisement